• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

Introduction to (3-Bromo-5-chloropyridin-2-yl)methanol (CAS No: 1227599-26-9)

(3-Bromo-5-chloropyridin-2-yl)methanol, with the CAS number 1227599-26-9, is a significant intermediate in the field of pharmaceutical and agrochemical research. This compound, featuring a pyridine core substituted with bromo and chloro groups, has garnered attention due to its versatile reactivity and potential applications in the synthesis of various bioactive molecules.

The structural motif of 3-Bromo-5-chloropyridin-2-yl)methanol makes it a valuable building block for medicinal chemists. The presence of both bromo and chloro substituents on the pyridine ring enhances its utility in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular frameworks. These reactions are widely employed in the development of novel therapeutic agents.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting various biological pathways. The pyridine scaffold is particularly prominent in this domain due to its ability to interact with biological targets through hydrogen bonding and hydrophobic interactions. The introduction of halogen atoms further modulates these interactions, making 3-Bromo-5-chloropyridin-2-yl)methanol an attractive candidate for drug discovery programs.

One of the most compelling applications of 3-Bromo-5-chloropyridin-2-yl)methanol is in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is associated with numerous diseases, including cancer. By leveraging the reactivity of the bromo and chloro groups, researchers have been able to develop potent and selective kinase inhibitors. For instance, derivatives of this compound have shown promising activity against tyrosine kinases, which are key targets in oncology.

The methanol moiety in the name (3-Bromo-5-chloropyridin-2-yl)methanol also contributes to its chemical versatility. The hydroxyl group can participate in various chemical transformations, including etherification, esterification, and oxidation reactions. These transformations allow for further functionalization of the molecule, enabling the synthesis of a wide range of derivatives with tailored biological activities.

Recent studies have highlighted the importance of halogenated pyridines in medicinal chemistry. The halogen atoms not only serve as handles for further functionalization but also influence the electronic properties of the pyridine ring. This modulation can lead to changes in binding affinity and selectivity towards biological targets. For example, computational studies have demonstrated that the presence of bromo and chloro groups can enhance interactions with specific amino acid residues in protein binding pockets.

The synthesis of 3-Bromo-5-chloropyridin-2-yl)methanol typically involves multi-step organic reactions starting from commercially available pyridine precursors. The introduction of bromo and chloro substituents can be achieved through halogenation reactions, often employing reagents such as N-bromosuccinimide (NBS) or phosphorus oxychloride (POCl?). The subsequent methylation step to introduce the hydroxymethyl group can be performed using reagents like formaldehyde or sodium borohydride.

In conclusion, (3-Bromo-5-chloropyridin-2-yl)methanol (CAS No: 1227599-26-9) is a versatile intermediate with significant potential in pharmaceutical research. Its unique structural features make it an excellent candidate for synthesizing bioactive molecules, particularly kinase inhibitors. The continued exploration of halogenated pyridines will likely lead to new insights and advancements in drug discovery.

• 1206968-88-8((5-Bromo-3-chloropyridin-2-yl)methanol)
• 1379316-16-1((3-bromo-6-methyl-2-pyridyl)methanol)
• 1227601-36-6((3,5-Dibromopyridin-2-yl)methanol)
• 2170188-53-9((3-Bromopyridin-2-yl)methan-d2-ol CAS：2170188-53-9)
• 1189513-50-5(3-Bromo-5-chloropyridine-2-carboxylic acid)
• 1374651-62-3(1-(3-bromo-5-chloropyridin-2-yl)ethanol)
• 52378-64-0((3-bromo-2-pyridyl)methanol)
• 131036-39-0(3-Bromo-5-chloro-2-methylpyridine)
• 1227601-71-9((3-bromo-6-chloro-2-pyridyl)methanol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)